4D Molecular Therapeutics (FDMT) closed at $12.62 on October 21, 2026, down 3.7% from the previous close, on volume of 1,988,412 shares (30-day average 937,890).
Data as of October 21, 2026.
21-Oct-2026
TipRanks (Thu, 22-Oct 6:00 AM ET)
TipRanks (Tue, 20-Oct 9:00 AM ET)
4DMT Announces New Employment Inducement Grants
Globe Newswire (Fri, 16-Oct 4:05 PM ET)
FDMT Sets October 21, 2026 Investor Day Spotlighting Phase 3 Retina Program 4D-150
Market Chameleon (Mon, 5-Oct 7:53 AM ET)
4DMT to Host Investor Day on October 21, 2026
Globe Newswire (Mon, 5-Oct 8:00 AM ET)
Globe Newswire (Mon, 28-Sep 8:00 AM ET)
4DMT to Participate in Upcoming Investor Conferences
Globe Newswire (Tue, 25-Aug 8:00 AM ET)
Globe Newswire (Thu, 13-Aug 4:05 PM ET)
FDMT Secures $100 Million in Fresh Funding: New Offering Expands Clinical Ambitions
Market Chameleon (Thu, 6-Nov 3:05 AM ET)
Market Chameleon (Fri, 31-Oct 3:07 AM ET)
4D Molecular Therapeutics Inc is biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment paradigms and provide unprecedented benefits to patients. Companies focus is on advancing 4D-150 for wet age-related macular degeneration (wet AMD) and diabetic macular edema (DME) through late-stage studies. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-710 and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector).
4D Molecular Therapeutics trades on the NASDAQ stock market under the symbol FDMT.
As of October 21, 2026, FDMT stock price declined to $12.62 with 1,988,412 million shares trading.
FDMT has a beta of 1.29, meaning it tends to be more sensitive to market movements. FDMT has a correlation of 0.05 to the broad based SPY ETF.
FDMT has a market cap of $697.18 million. This is considered a Small Cap stock.
Last quarter 4D Molecular Therapeutics reported $4 million in Revenue and -$1.04 earnings per share. This beat revenue expectation by $1 million and missed earnings estimates by -$.02.
In the last 3 years, FDMT traded as high as $36.25 and as low as $2.24.
The top ETF exchange traded funds that FDMT belongs to (by Net Assets): VTI, XBI, IWM, VXF, IWN.
FDMT has underperformed the market in the last year with a return of +12.0%, while SPY returned +16.3%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in FDMT shares. However, FDMT has outperformed the market in the last 3 month and 2 week periods, returning +13.8% and +0.5%, while SPY returned +4.4% and -0.8%, respectively. This indicates FDMT has been having a stronger performance recently.
FDMT support price is $12.55 and resistance is $13.66 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that FDMT shares will trade within this expected range on the day.
